MARIE BURTON: Open Payments
NPI 1568619302 · WEST HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$667 in 24 payments from 16 companies in 2025. Trend: 2023 $467 · 2024 $535 · 2025 $667
Food & beverage: $667
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $150 |
| GlaxoSmithKline, LLC. | 4 | $83 |
| PFIZER INC. | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $63 |
| Sumitomo Pharma America, Inc. | 2 | $56 |
| ABBVIE INC. | 1 | $31 |
| Novo Nordisk Inc | 1 | $29 |
| Boston Scientific Corporation | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Ardelyx, Inc. | 1 | $25 |
Products named: REZDIFFRA, TRELEGY ELLIPTA, AIRSUPRA, GEMTESA, PREVNAR 20, UBRELVY, Ozempic, FARAPULSE.
Industry payments across CT — which companies pay providers there.
